Fifth Third Bancorp Repligen Corp Transaction History
Fifth Third Bancorp
- $25.9 Billion
- Q1 2025
A detailed history of Fifth Third Bancorp transactions in Repligen Corp stock. As of the latest transaction made, Fifth Third Bancorp holds 5,734 shares of RGEN stock, worth $829,996. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,734
Previous 4,267
34.38%
Holding current value
$829,996
Previous $614,000
18.73%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding RGEN
# of Institutions
482Shares Held
56.6MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.1 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.03 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$738 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$245 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$223 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.03B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....